Lipoxygenase
Lipoxygenase(脂氧合酶)
Lipoxygenases (LOXs) are dioxygenases that catalyze the formation of corresponding hydroperoxides from polyunsaturated fatty acids such as linoleic acid and arachidonic acid. Thre are six LOX isoforms have been found in the humans and mice. 5-Lipoxygenase (5-LOX) is a distinct isoform playing an important role in asthma and inflammation. 5-LOX causes the constriction of bronchioles in response to cysteinyl leukotrienes such as LTC4, thus leading to asthma. 5-LOX also induces neutrophilic inflammation by its recruitment in response to LTB4. 12-Lipoxygenase (12-LOX) is an isoform expressed in epithelial cells and myeloid cells including platelets. 12-LOX can be found in the epithelial cells of the skin. 12-LOX is a potential target for novel anti-platelet therapeutics.15-Lipoxygenase (15-LOX) is expressed in epithelial cells and leukocytes, has different substrate specificity in the humans and mice.15-LOX-1 is a target of nonsteroidal anti-inflammatory drug-induced apoptosis in colorectal cancer cells.
Lipoxygenase 相关产品(254)
- GC44212MK-886 (sodium salt)CAS: 118427-55-7纯度: >99.00%
A potent, selective inhibitor of 5-lipoxygenase-activating protein (FLAP)
- GC44295N-acetyl Leukotriene E4CAS: 80115-95-3纯度: >97.00%
The major inactive metabolite of LTE 4 found in bile
- GC4642013(S)-HODE-d4CAS: 139408-39-2纯度: >99.00%
An internal standard for the quantification of 13-HODE
- GC4644215(S)-HETE-d8CAS: 84807-87-4纯度: >99.00%
An internal standard for the quantification of 15(S)-HETE
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC44212 | MK-886 (sodium salt) | 118427-55-7 | >99.00% | |
A potent, selective inhibitor of 5-lipoxygenase-activating protein (FLAP) | ||||
| GC44295 | N-acetyl Leukotriene E4 | 80115-95-3 | >97.00% | |
The major inactive metabolite of LTE 4 found in bile | ||||
| GC44415 | N-methyl Leukotriene C4 | 131391-65-6 | >97.00% | |
A stable LTC 4 mimetic | ||||
| GC44579 | PCTR1 | 1810710-59-8 | >96.00% | |
A specialized pro-resolving mediator | ||||
| GC44580 | PCTR2 | 1810710-63-4 | >96.00% | |
A specialized pro-resolving mediator | ||||
| GC44581 | PCTR3 | 1810710-69-0 | >96.00% | |
A specialized pro-resolving mediator | ||||
| GC44818 | Resolvin D4 | 1025684-60-9 | >95.00% | |
A pro-resolving mediator | ||||
| GC44879 | Sclerotiorin | 549-23-5 | >98.00% | |
A natural compound with LOX and CETP inhibitory activity | ||||
| GC45024 | tetranor-12(S)-HETE | 121842-79-3 | - | |
A peroxisome metabolite of 12(S)-HETE | ||||
| GC45768 | Pranlukast-d4 | 2713172-43-9 | >99.00% | |
A neuropeptide with diverse biological activities | ||||
| GC45931 | 4(S),11(R)-DiHDoHE | - | >95.00% | |
A neuropeptide with diverse biological activities | ||||
| GC45948 | 1,2,3-Trilinoelaidoyl-rac-glycerol | 5188-25-0 | >98.00% | |
A triacylglycerol | ||||
| GC45951 | BLX3887 | 934758-70-0 | >95.00% | |
A 15-LO-1 inhibitor | ||||
| GC45960 | 9c(i472) | 2349374-37-2 | >95.00% | |
A 15-LO-1 inhibitor | ||||
| GC46048 | 17(S)-HDHA-d5 | 2738376-87-7 | >99.00% | |
A neuropeptide with diverse biological activities | ||||
| GC46057 | 2,5-Dihydroxycinnamic Acid phenethyl ester | 179691-97-5 | >98.00% | |
An inhibitor of 5-LO | ||||
| GC46105 | Butyrolactone II | 87414-44-6 | >95.00% | |
A fungal metabolite | ||||
| GC46416 | 12-epi Leukotriene B4-d4 | - | >99.00% | |
A neuropeptide with diverse biological activities | ||||
| GC46418 | 12-oxo-13-HOME | 5502-89-6 | >95.00% | |
An oxylipin | ||||
| GC46420 | 13(S)-HODE-d4 | 139408-39-2 | >99.00% | |
An internal standard for the quantification of 13-HODE | ||||
| GC46436 | 13-OxoODE-d3 | - | >99.00% | |
A neuropeptide with diverse biological activities | ||||
| GC46441 | 15(S)-HEPE-d5 | 2750534-74-6 | >99.00% | |
A neuropeptide with diverse biological activities | ||||
| GC46442 | 15(S)-HETE-d8 | 84807-87-4 | >99.00% | |
An internal standard for the quantification of 15(S)-HETE | ||||
| GC46457 | 17(R)-Resolvin D1-d5 | - | >99.00% | |
A neuropeptide with diverse biological activities | ||||
